Deletion of the MTO2 gene related to tRNA modification causes a failure in mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae  by Wang, Xinjian et al.
FEBS Letters 581 (2007) 4228–4234Deletion of the MTO2 gene related to tRNA modiﬁcation causes
a failure in mitochondrial RNA metabolism in the yeast
Saccharomyces cerevisiae
Xinjian Wanga, Qingfeng Yana, Min-Xin Guana,b,*
a Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA
b Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, USA
Received 8 April 2007; revised 17 July 2007; accepted 26 July 2007
Available online 7 August 2007
Edited by Lev KisselevAbstract We report here the characterization of the yeast mto2
null mutants carrying wild-type mitochondrial DNA or 15S
rRNA C1049G allele. The amounts of mitochondrial tRNALys,
tRNAGlu, tRNAGln, tRNALeu, tRNAGly and tRNAMet were
markedly decreased but those of tRNAArg and tRNAHis were
not aﬀected in mto2 strains. The mto2 strains exhibited signiﬁ-
cant reduction in the aminoacylation of tRNALys, tRNALeu but
almost no eﬀect in those of tRNAHis. Interestingly, the strain
carrying the C1049G allele exhibited an impairment of amino-
acylation of those tRNAs. Furthermore, the steady-state levels
of mitochondrial mRNA CYTB, COX1, COX2, COX3, and
ATP6 were markedly decreased in mto2 strains. These data
strongly indicate that unmodiﬁed tRNA caused by the deletion
of MTO2 caused the instability of mitochondrial tRNAs and
mRNAs and impairment of aminoacylation of tRNAs.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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All tRNA species contain modiﬁed nucleotides, which are
derivatives of the four normal nucleotides adenosine (A), gua-
nosine (G), uridine (U) and cytidine (C) [1,2]. Of these, the
nucleotide at the position 34 (wobble position of anticodon)
of tRNA is more prone to modiﬁcation than those at other
positions of tRNA [3]. In particular, 2-thiouridine (s2U34)
modiﬁcation at the wobble position 34 is phylogenetically con-
served in tRNAGlu, tRNALys and tRNAGln from all organisms
[3–5]. In fact, glutamate, lysine and glutamine are encoded by
two degenerate codons ending in purine (NNR) in the two-
codon boxes that specify two amino acids by diﬀerence in the
third codon bases in the genetic code. In the decoding region
of the small subunit of ribosome, 2-thio allows U34 to adopt
the C3 0-endo puckering conformation of the ribose, facilitatingAbbreviations: PCR, polymerase chain reaction; DIG, digoxingenin;
PR, paromomycin resistance; PS, paromomycin sensitivity; mtDNA,
mitochondrial DNA
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decoding of the NNR codon, thereby contributing to ﬁdelity
[7–10]. Furthermore, s2U34 serves as an important recognition
determinant for cognate aminoacyl-tRNA synthetases that are
speciﬁc for tRNA containing this base [8,11]. In Escherichia
coli, TrmU thiouridylase speciﬁcally synthesizes the s2U34
modiﬁcation of tRNAGlu, tRNALys and tRNAGln [12]. Such
2-thiouridine modiﬁcations, synthesized by the TRMU-liked
tRNA modifying enzymes, were also found in the wobble
position of the yeast and human mitochondrial tRNAGlu,
tRNALys and tRNAGln [13–16]. In fact, a human TRMU
mutation led to a failure in 2-thiouridine modiﬁcation of mito-
chondrial tRNALys, tRNAGlu and tRNAGln, thereby reducing
the steady-state levels of these tRNAs [15]. The disruption of
MTO2/MTU1 (homolog of TrmU) in the yeast Saccharomyces
cerevisiae led to the complete loss of 2-thiouridylation in the
mitochondrial tRNALys, tRNAGlu and tRNAGln [15].
In the previous studies, we showed that the S. cerevisiae
mto2 null mutant expressed the respiratory deﬁcient phenotype
only when coexisting with a paromomycin resistance C1409G
mutation of mitochondrial 15S rRNA, at the very conservative
decoding site, corresponding to human deafness-associated
mitochondrial 12S rRNA A1491G and C1409T mutations
[16,17]. Furthermore, mto2 mutants exhibited alterations in
the mitochondrial protein synthesis and expression of mito-
chondrial gene, especially in CYTB and COX1 in the context
of the mitochondrial 15S rRNA C1409G [16]. These strongly
indicate that the product of MTO2 functionally interacts with
the decoding region of 15S rRNA, particularly at site of
C1409G or A1491G mutation. Subsequent investigations indi-
cate that the human mutated TRMU, acting as a modiﬁer
factor, modulates the phenotypic manifestation of the deaf-
ness-associated mitochondrial 12S rRNA mutations [18]. To
further understand the role of MTO2 in mitochondrial RNA
metabolism, the yeast mto2 null mutants have been character-
ized by examining the steady-state level and aminoacylation
capacity of mitochondrial tRNA, the stability of mitochon-
drial mRNAs as well as the frequency of petite formation.2. Materials and methods
2.1. Yeast strains and media
The genotypes of strains used in this investigation were: M12 (a, ilv5,
trp2, MTO2), M12-54 (a, ilv5, trp2, MTO2 [PR]) [19], DMTO2 PS (a,
ade2-1, his3-1, leu2-3, ura3-1, mto2::HIS3), and DMTO2PR (a, ade2-
1, his3-1, lys2, ura3-1, mto2::HIS3 [PR]) [16]. The YPH500 q strainblished by Elsevier B.V. All rights reserved.
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growth technique using ethidiumbromide [20]. These yeast strains car-
ried either wild type paromomycin sensitivity mtDNA (PS) or a paro-
momycin resistance C1409G allele (PR). The complete media for yeast
cell growth consists of 0.5% yeast extract Difco (Y), 1% Bacto-Peptone
Difco (P), and a carbon source as speciﬁed [21]. GYP medium contains
Y, P and 2% glucose. GlyYP contains Y, P and 2% glycerol.
2.2. Petite production analysis
Yeast cells were grown in liquid GYP medium overnight, then
diluted and spread on GYP medium plates. After incubation at
30 C for 2 days, cells were replica-plated onto GlyYP medium and
incubated for 4 days. Petite were scored as small colonies were grown
in GYP medium but were unable to grow in GlyYP medium. At least
400 colonies for each strain were scored in GYP medium. Frequency of
petite formation was deﬁned as numbers of petites/total colonies in
GYP medium in each strain.
To distinguish nuclear petite mutants from mitochondrial petite
mutants, 100 single clones, which were unable to grow in GlyYP medium,
for each strain, were crossed to the opposite mating type wild type q0
strain YPH500 in 5% GYP medium, plated on 2% glucose minimal
medium and glycerol minimal medium. After growth at 30 C for
5 days, the diploid progeny were checked for their growth. The diploid
strains showing growth on glycerol medium revealed that the nuclear
gene mutation is responsible for the petite phenotype, while the inabil-
ity to grow on glycerol medium in diploid strains indicated that these
petites were cytoplasmic petites [22].
2.3. Mitochondrial tRNA Northern blot analysis
Total mitochondrial RNAs were obtained using TOTALLY RNA
kit(Ambion) from mitochondria isolated from yeast cells, as described
previously [16,23]. Two microgram of total mitochondrial RNA were
electrophoresed through a 10% polyacrylamide/7 M urea gel in Tris–
borate–ethylenediaminetetraacetic acid buﬀer (after heating the sample
at 65 C for 10 min), and then was electroblotted onto a positively
charged nylon membrane (Roche) for the hybridization analysis with
speciﬁc oligodeoxynucleotide mitochondrial tRNA probes. For the
detection of tRNAArg, tRNALeu, tRNALys, tRNAGly, tRNAGlu,
tRNAGln, tRNAMet, and tRNAHis, the following non-radioactive
digoxingenin-(DIG-) labeled oligodeoxynucleotides speciﬁc for tRNAs
were used: 5 0-TGGTACTCTCTCCATGATTTGAAC-3 0(tRNAArg);
5 0-TGGTGCTATTTAAAGGACTTGAACCTT-30(tRNALeu); 5 0-TG-
GTGAGAATAGCTGGAGTTGAAC-30(tRNALys); 5 0-TGGTAT-
AGATAGCGAGAATCGAAC-3 0(tRNAGly); 5 0-TGGTAACCTT-
AATCGGAATCGGAATCGAAC-3 0(tRNAGlu); 5 0-TGGTTGAAT-
CGGTTTGATTCGAAC-3 0(tRNAGln); 5 0-TGGTACTTGTAGAA-
GGAATTGAAC-3 0(tRNAMet); 5 0-TGGGGTGAATACTGAGAAT-
CGAACTCA-3 0(tRNAHis) (GenBank accession no: AJ011856) [24].
DIG-labeled oligodeoxynucleotideswere generated by using the DIG
oligonucleotide Tailing kit (Roche). The hybridization was performed
as detailed elsewhere [16,23]. Quantiﬁcation of density in each band
was made as detailed elsewhere [18,23,25].
2.4. Mitochondrial tRNA aminoacylation analysis
Total mitochondrial RNAs were isolated as above but under acid
condition. The total mitochondrial RNA (2 lg) was electrophoresed
at 4 C through an acid 10% polyacrylamide/7 M urea gel in a 0.1 M
sodium acetate (pH 5.0) to separate the charged and uncharged tRNA,
as detailed elsewhere [26,27]. Then RNAs were electro-blotted onto a
positively charged membrane (Roche) and hybridized sequentially with
the speciﬁc tRNA probes as above.
2.5. Mitochondrial mRNA analysis
Total cellular RNA was obtained using a Totally RNA kit (Am-
bion) from midlog phase yeast cultures (2.0 · 107 cells) according to
the manufacturer’s instructions. Equal amounts (20 lg) of total
RNA were fractionated by electrophoresis through a 1.8% agarose-
formaldehyde gel, transferred onto a positively charged membrane
(Roche Applied Science), and initially hybridized with a probe speciﬁc
for CYTB RNA. The probe was synthesized on the corresponding
restriction enzyme-linearized plasmid using a DIG RNA labeling kit
(Roche Applied Science). RNA blots were then stripped and rehybrid-
ized with DIG-labeled COX1, COX2, COX3, ATP6, and ATP9
probes, respectively [16]. As an internal control, RNA blots werestripped and rehybridized with a DIG-labeled nuclear 25S rRNA
probe. The plasmids used for CYTB, COX1 and 25S rRNA probes
were as described previously [16]. The other plasmids used for mtDNA
probes were constructed by PCR-amplifying fragments of COX2 (posi-
tions 74158–74472), COX3 (positions 796084–79967), ATP6 (positions
28829–29227) and ATP9 (positions 46738–46949) (GenBank accession
no: AJ011856) [24], and then cloning the fragments into the pCRII-
TOPO vector carrying SP6 and T7 promoters (Invitrogen).3. Results
3.1. mto2 mutation leads to a decrease of steady-state level of
mitochondrial tRNAs
To examine if the mto2 mutation alters the stability of mito-
chondrial tRNAs, the steady-state levels of the tRNAs were
determined by isolating total mitochondrial RNA from four
yeast strains, separating them by a 10% polyacrylamide/7 M
urea gel, electroblotting and hybridizing with non-radioactive
DIG-labeled oligodeoxynucleotide probes speciﬁc for
tRNALys, tRNAGlu, tRNAGln, tRNALeu, tRNAGly, tRNAMet,
tRNAArg and tRNAHis, respectively. As illustrated in Fig. 1A,
the amounts of tRNALys, tRNAGlu, tRNAGln, tRNALeu,
tRNAGly and tRNAMet were markedly decreased but those
of tRNAArg and tRNAHis were not aﬀected in mto2 mutant
cells carrying either wild-type paromomycin sensitivity
mtDNA (PS) or a paromomycin resistance C1409G allele
(PR), compared with the MTO2 wild type cells.
For comparison, the average levels of each tRNA in the var-
ious control or mutant yeast strains were then normalized to
the average levels in the same strain for the tRNAArg and
tRNAHis, respectively. As shown in Fig. 1B, the average stea-
dy-state levels of those tRNAs were signiﬁcantly decreased in
the mto2 mutant strain carrying either PS or PR allele, com-
pared with the wild type strain M12. The average levels of
tRNAs in the mto2 (PR) strain are 29% in the tRNALys, 36%
in tRNAGlu, 37% in tRNAGln, 74% in tRNALeu, 19% in
tRNAGly, and 33% in tRNAMet of control levels (M12) after
normalization to tRNAArg. Similarly, the average levels of
tRNAs in mto2 (PR) strain are 19% in the tRNALys, 24% in
tRNAGlu, 24% in tRNAGln, 48% in tRNALeu, 13% in tRNAGly
and 22% in tRNAMetof control levels (M12) after normaliza-
tion to tRNAHis. Furthermore, the average levels of those
tRNAs in mto2 strains with wild type mtDNA background
were comparable to those of mto2 strain carrying the PR allele.
In addition, there is no signiﬁcant reduction in the average lev-
els of mitochondrial tRNAs between the MTO2 strain M12
carrying PS allele and the MTO2 strain M12-54 carrying the
PR allele. These data indicate that the mto2 mutation leads
to marked reductions in the steady-state level of mitochondrial
tRNAs, independently of the paromomycin resistance allele.
3.2. mto2 mutation alters aminoacylation of mitochondrial
tRNA
It has been shown that the s2U34 serves as a determinant for
tRNA recognition by cognate aminoacyl-tRNA synthetases in
E. coli [8,11]. This led us to test whether the mto2 mutation
aﬀects the aminoacylation of mitochondrial tRNAs. For this
purpose, the aminoacylation capacity of mitochondrial
RNALys, tRNALeu and tRNAHis in wild-type and mutant
strains were carried out by the use of electrophoresis in an acid
polyacrylamide/urea gel system to separate un-charged tRNA
species from the corresponding charged tRNA [26,27]. As
Fig. 1. Northern-blot analysis of mitochondrial tRNA. (A) Equal amounts (2 lg) of total mtRNA samples from the wild type and mutant yeast
strains were electrophoresed through a denaturing polyacrylamide gel, electroblotted and hybridized with DIG-labeled oligonucleotide probes
speciﬁc for the mitochondrial tRNALys. The blots were then stripped and re-hybridized with DIG-labeled probes for tRNAGlu, tRNAGln, tRNALeu,
tRNAGly, tRNAMet, tRNAArg, and tRNAHis, respectively. (B). Quantiﬁcation of the levels of mitochondrial tRNA. Average relative tRNALys,
tRNAGlu, tRNAGln, tRNALeu, tRNAGly, and tRNAMet content per cell, was normalized to the average content per cell of tRNAArg or tRNAHis. The
values for the latter were expressed as percentages of the average values for the wild strain MTO2 (PS). The calculations were based on the three
independent determinations of each tRNA content in each yeast strain and three determinations of the content of each reference tRNA marker in
each strain.
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tRNA, and the lower band was uncharged tRNA. The propor-
tions of aminoacylation of the mitochondrial-tRNA in the
wild type strain M12 (MTO2, PS) were 54%, 37% and 44%
in the tRNALys, tRNALeu and tRNAHis, respectively. There
were no obvious diﬀerences in electrophoretic mobility be-
tween wild type strain M12 carrying the PS allele and mutant
strains. However, the mutant strains: the MTO2 strain M12-
54 carrying the PR allele, the mto2 strains carrying PS allele
or the PR allele showed a marked reduction in the eﬃciency
of charging tRNALys, tRNALeu but almost no eﬀect in those
of tRNAHis, as compared with the wild type strain M12. In
particular, the proportions of aminoacylation of the tRNALys
in strains carrying MTO2/PR, mto2/PS as well as mto2/PR
alleles were 27%, 26% and 26%, respectively, while the propor-
tions of aminoacylation of the tRNALeu in strains carrying
MTO2/PR, mto2/PS as well as mto2/PR alleles were 18%, 13%
and 14%, respectively.
3.3. mto2 mutation aﬀects the expression of mitochondrial
genome
In the previous studies, we showed that the mto2 mutant had
lower levels of mature CYTB and COX1 mRNA and accumu-lated unprocessed or partially processed precursors in the pres-
ence of the 15S rRNA C1409G allele [16]. We therefore
examined whether the mto2 null mutation also aﬀected the
expression of other mitochondrial genes by Northern blot
analysis. For this purpose, RNA blots were hybridized with
DIG-labeled probes for exon regions of CYTB, COX1,
COX2, COX3, ATP6, and ATP9 probes, respectively. In these
mitochondrial genes, CYTB consists of six exons and ﬁve in-
trons, and COX1 contains 8 exons and 7 introns,whereasCOX
2, COX3, ATP6, and ATP9 gene lack any introns [24]. As an
internal control, RNA blots were stripped and rehybridized
with the DIG-labeled nuclear-encoded 25S rRNA probe. As
shown in Fig. 3A, the amounts of mature CYTB and COX1
mRNA as well as COX2, COX3, ATP6 mRNA but not
ATP9 were decreased in the mto2/PR strain, compared with
the wild type MTO2 strain carrying the 15S rRNA PR allele.
For comparison, the average levels of each mRNA in the var-
ious strains were then normalized to the average levels in the
same strain for the reference 25S rRNA. As shown in
Fig. 3B, the average steady-state levels of most mRNAs were
decreases in the mto2 mutant cells, relative to the control
(MTO2 strain carrying the15S rRNA PS allele). In particular,
the steady-state levels of mRNAs in mto2/PR cells were 42% in
Fig. 3. Northern blot analysis of mitochondrial mRNAs. (A) Equal amounts (20 lg) of total cellular RNA from various mutant and control strains
were electrophoresed through a 1.8% agarose-formaldehyde gel, transferred onto a positively charged membrane and hybridized ﬁrst with a DIG-
labeled CYTB speciﬁc RNA probe. After stripping, the blots were rehybridized with DIG-labeled mtRNA probes COX1, COX2, COX3, ATP6, and
ATP9 probes, respectively. Subsequently, after re-stripping, the blots were hybridized with a DIG-labeled nuclear 25S RNA probe as an internal
control. (B). Quantiﬁcation of the levels of mitochondrial mRNA. Average relative CYTB, COX1, COX2, COX3, ATP6, and ATP9 mRNA content
per cell normalized to the average content per cell of 25S rRNA in mutant and control strains. Three independent determinations of mRNA content

























































Fig. 2. In vivo aminoacylation assays for mitochondrial tRNA. (A) Equal amounts (2 lg) of total mitochondrial RNA puriﬁed from various yeast
strains under acid conditions were treated with electrophoresis at 4 C through an acid (pH 5.1) 10% polyacrylamide/7 M urea gel, electroblotted
onto a positively charged nylon membrane, and hybridized with DIG-labeled oligonucleotide probes speciﬁc for mitochondrial tRNALys. The blots
were then stripped and rehybridized with DIG-labeled probes for tRNALeu and tRNAHis, respectively. (B) Quantiﬁcation of the levels of
aminoacylated mitochondrial tRNALys, tRNALeu and tRNAHis. The calculations were based on the three independent determinations of each tRNA
in each yeast strain.
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COX3, 69% in ATP6 and 100% in ATP9 of control levels. Fur-
thermore, the steady-state levels of mRNAs in mto2/PS cells
were 62% in mature CYTB, 28% in mature COX1, 88% in
COX2, 67% in COX3, 66% in ATP6 and 113% in ATP9 of con-
trol levels. It is noted that the levels of mature COX1 mRNA
in mto2 cells with PS or PR allele were only 28% of control,
while the levels of this mRNA in mto2/PS cells was comparable
with those of controls in our previous study [16]. This discrep-
ancy is likely due to these mto2 strains derived from diﬀerent
nuclear background. In addition, the levels of all those mito-chondrial mRNAs in MTO2 cells carrying the 15S rRNA PR
allele were comparable with those of controls.
3.4. mto2 mutation causes the formation of petites
Our previous study indicated that the mto2 mutant in the
15S rRNA PS and PR alleles exhibited slow growth or inability
to grow on glycerol medium, respectively, suggesting that the
mto2 mutation increased the petite formation [16]. The rate
of petite production in the wild type strain (MTO2/PS) is
2.7%, while that of MTO2 strain in the 15S rRNA PR allele
was 19.5%. This suggested that the 15S rRNA PR allele also
4232 X. Wang et al. / FEBS Letters 581 (2007) 4228–4234increased the petite production. However, the rates of petite
production in the mto2 mutant carrying the 15S rRNA PS
and PR allele were 25.9% and 99.7%, respectively. To distin-
guish nuclear petite mutants from cytoplasmic petite mutants
in mto2 strains, 100 single clones, which were unable to grow
in GlyYP medium, for each strain, were crossed to the oppo-
site mating type wild type q strain YPH500. The diploid prog-
eny were checked for their growth in glycerol and glucose
media. The diploid strains showing growth on glycerol med-
ium revealed that the mto2 mutation is responsible for the pe-
tite phenotype, while the inability to grow on glycerol medium
in diploid strains indicated that the petites were cytoplasmic
petites [22]. Of these, the cytoplasmic petites account for
97.6%, 2.1% and 43.5% of total petite production in the
MTO2 strain carrying the PR allele, the mto2 mutant carrying
the 15S rRNA PS and PR allele, respectively.4. Discussion
In this study, we have further characterized the yeastMTO2,
a nuclear gene encoding a mitochondrial protein responsible
for the biosynthesis of hypermodiﬁed 2-thiouridine (s2U34)
in the wobble position of tRNALys, tRNAGlu and tRNAGln
[4,15]. The s2U34 is further modiﬁed to mnm5s2U34 in the
same position of those tRNAs in E. coli, yeast and human
mitochondria [3,5,28]. Indeed, this modiﬁed nucleotide plays
a pivotal role in the structure and function of tRNAs. Defects
in biosynthesis of this modiﬁed nucleotide in the E. coli have
been shown to aﬀect structural stabilization [29], to cause
impairment of aminoacylation [8,11] and alteration of
codon–anticodon interaction [30]. In particular, the deﬁcient
biosynthesis of this modiﬁed nucleotide in the E. coli increased
the frequency of translation frameshifting, thereby aﬀecting
the ﬁdelity and eﬃciency of translation [10,28,31,32]. The dis-
ruption of yeast MTO2/MTU1 led to a failure in 2-thiouridy-
lation in mitochondrial tRNALys, tRNAGlu and tRNAGln [15],
thereby causing a large proportion of unmodiﬁed mitochon-
drial tRNAs. Here, the deﬁciency of this nucleotide thiouridy-
lation, like those in the E. coli, may alter the structure and
function of these mitochondrial tRNAs including the stability,
aminoacylation of tRNA and codon-anticodon interaction.
Consequently, the mto2 mutation may aﬀect the ﬁdelity and
eﬃciency of mitochondrial protein synthesis, as in the case of
E. coli trmU mutations [10].
These unmodiﬁed tRNAs caused by the deletion of MTO2,
similar to those in cell lines carrying the A10S mutation in hu-
man TRMU [18], likely makes tRNAs more unstably, thus
reducing the levels of mitochondrial tRNALys, tRNAGlu and
tRNAGln. In fact, the decreases of 75%, 70% and 70% in
the steady state levels of tRNALys, tRNAGlu and tRNAGln in
mto2 mutant cells carrying the PS or PR allele were consistent
with the loss of 2-thiouridylation in these tRNAs. Further-
more, the steady-state levels of mitochondrial tRNALeu,
tRNAGly, and tRNAMet were also decreased signiﬁcantly in
mto2 mutant cells carrying the PS or PR allele, while those of
tRNAArg, and tRNAHis were not aﬀected in the mto2 strains.
In fact, the nucleotides at position 34 of other yeast mitochon-
drial tRNAs are uridine for tRNALeuand tRNAGly, cytidine
for tRNAMet, adenosine for tRNAArg and guanosine for
tRNAHis, respectively [3,5,24]. Other type modiﬁcations rather
than 2-thio modiﬁcation occurs in the wobble position of thosemitochondrial tRNAs [5,6,14]. However, the 2-thiouridine,
synthesized by the participation of Mto2p, may be the precur-
sor of other modiﬁed nucleotides of the xm5 (s2) U(m)-type
found in the tRNAs reading A or G in the third position of
the code for two amino acids such as tRNALeu (cmnm5Um)
but not those nucleotides at position 34 with purines such as
tRNAArg and tRNAHis [5]. Thus, the deletion of MTO2 also
results in the reduction of steady-state levels in the tRNALeu,
tRNAGly, and tRNAMet, but not those in tRNAArg and
tRNAHis. Alternatively, the loss of Mto2p activity likely leads
to transcriptional/translational defects and thereby reduces the
steady-state levels of those tRNAs.
The s2U34 is known to function as a recognition element for
the glutaminyl, lysyl and glutamyl-tRNA synthesis [8,11]. The
unmodiﬁed tRNAGlu derived from in vitro transcription was a
very poor substrate for the glutamyl-tRNA synthestase and
exhibited more than a 100-fold reduction in the speciﬁcity
compared to the native tRNAGlu in E. coli [11]. Similarly,
the unmodiﬁed tRNALys obtained through in vitro transcript
had a 140-fold reduced lysine charging eﬃciency [33]. Here,
the mitochondrial tRNALys and tRNALeu were uncharged to
a signiﬁcantly high degree in vivo in mto2 mutants carrying
the PS or PR allele, compared to the MTO2 wild type strain
M12 carrying PS allele. On the other hand, there was no diﬀer-
ence in the aminocylated levels of mitochondrial tRNAHis
between the mutant and wild type strains. These data clearly
indicated that the loss of synthesis of s2 U34 by the deletion
of MTO2 gave rise to an impairment of aminoacylation of
mitochondrial tRNALys and tRNALeu but not in tRNAHis.
Furthermore, it is worthwhile to note that the 15S rRNA
C1409G mutation led to a defect in aminoacylation of mito-
chondrial tRNALys, tRNALeu and tRNAHis. It was suggested
that the C1494G mutation caused a local conformational
change in the A-site of mitochondrial 15S rRNA, thereby
aﬀecting the eﬃciency and accuracy of codon-anticodon inter-
action [16]. In fact, those ribosomes carrying the mutated yeast
mitochondrial 15S rRNA had a decreased level of natural
frameshifting, suggesting a more stringent proofreading [34].
As a result, these structural and functional alterations may
be responsible for the impairment of aminoacylation of these
mitochondrial tRNAs, thereby causing a mild defect in mito-
chondrial translation [16] and 20% petite formation in the
strain carrying the 15S rRNA C1409G mutation.
In addition, the deletion of MTO2 aﬀects the mitochondrial
mRNA metabolism. Here, the steady-state levels of mitochon-
drial mRNAs such as CYTB, COX1, COX2, COX3 and ATP6
were decreased in mto2 cells carrying either wild type mtDNA
background or the 15S rRNA C14049G allele, compared with
wild typeMTO2 strains. Likely, the unmodiﬁed mitochondrial
tRNAs caused by the deletion of MTO2 lead to transcrip-
tional/translational defects, thereby reducing the steady-state
levels of those mRNAs.
The observation that there were similar degrees of reduc-
tions in the steady-state level and aminoacrylation of mito-
chondrial tRNA in mto2 mutants carrying either carrying the
PS or PR allele suggested the eﬀects of mto2 mutation on mito-
chondrial tRNA metabolisms including the stability and
aminoacylation of tRNA were independently of the paromo-
mycin resistance allele.Thus, a failure in mitochondrial tRNA
metabolism, caused by the deletion ofMTO2 gene, most prob-
ably accounts for a marked decrease in the overall rate of mito-
chondrial translation [16] and the higher frequency (26%) of
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However, the mto2 mutation, in conjunction with the C1409G
mutation in 15S rRNA, led to nearly complete loss of the mito-
chondrial protein synthesis, thereby causing the accumulation
of unprocessed or partially processed precursors of CYTB and
COX1 and subsequent respiratory deﬁcient phenotype in the
mto2 mutants in the context of the mitochondrial 15S rRNA
C1409G allele [16], as in the cases of mss1 and mto1 mutants
[19,35]. The synergistic role of the mitochondrial 15S rRNA
C1409G allele in the respiratory deﬁcient phenotype in the
mto2 strains was further supported the observation that the
43.5% of petite production in the mto2 strain carrying the PR
allele are cytoplasmic petites and 56.5% of petite production
resulted from themto2 mutation.
In summary, the MTO2 encoded a mitochondrial protein
responsible for the biosynthesis of 2-thiouridine (s2U34) in
the wobble position of tRNALys, tRNAGlu and tRNAGln.
The unmodiﬁed mitochondrial tRNAs caused by the deletion
of MTO2 gene likely makes the tRNA more unstably, thus
reducing the levels of mitochondrial tRNALys, tRNAGlu and
tRNAGln. The unmodiﬁed mitochondrial tRNAs are poor sub-
strates for cognate aminoacyl-tRNA synthetases, thereby
decreasing the aminoacylation levels of mitochondrial tRNAs.
Furthermore, the unmodiﬁed mitochondrial tRNAs led to
transcriptional/translational defect and thereby reduced the
steady-state levels of mitochondrial RNA. Thus, a failure in
mitochondrial tRNA metabolism, caused by the deletion of
MTO2, is responsible for a marked decrease in the overall rate
of mitochondrial translation and subsequent respiratory deﬁ-
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